Anavex Life Sciences
AVXL
AVXL
57 hedge funds and large institutions have $23.8M invested in Anavex Life Sciences in 2018 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 15 increasing their positions, 15 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
2.71% less ownership
Funds ownership: 23.07% → 20.36% (-2.7%)
16% less capital invested
Capital invested by funds: $28.4M → $23.8M (-$4.55M)
79% less call options, than puts
Call options by funds: $195K | Put options by funds: $926K
Holders
57
Holding in Top 10
1
Calls
$195K
Puts
$926K
Top Buyers
| 1 | +$1.75M | |
| 2 | +$741K | |
| 3 | +$527K | |
| 4 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$502K |
| 5 |
BCM
BlueCrest Capital Management
St Helier,
Jersey
|
+$447K |
Top Sellers
| 1 | -$4.12M | |
| 2 | -$1.55M | |
| 3 | -$884K | |
| 4 |
TCIM
TIAA CREF Investment Management
New York
|
-$292K |
| 5 |
Bank of New York Mellon
New York
|
-$240K |